News

In addition to opening the door to developing blockers of odors, McClintock says this work will help researchers understand why formulating fragrances and flavors with specific properties is so difficult. “Ergo, the oft-used phrase 'the art of perfumery.' Eventually, we will turn this art into science.”

Two University of Kentucky faculty will be featured in an upcoming episode of “Your Fantastic Mind,” an Emmy-nominated television series featuring compelling stories on brain-related health and wellness.

“It’s difficult for people who use drugs to be open about [their drug use] because of the stigma it carries and the potential of criminal justice involvement,” Young said. “We tried to create a welcoming environment in our field office, and we put ourselves out there.”

The funding will further ongoing substance use disorder treatment research in collaboration with Sharon Walsh at the UK Center on Drug and Alcohol Research (CDAR) and Mei-Chuan Ko at the Wake Forest School of Medicine.

The team suggests a number of changes to help rebuild trust and reduce stigma for opioid use disorder in rural communities; they also suggest that wholesalers change algorithms to track buprenorphine separately from other opioids.

UK researchers hope to gain a better understanding of the effects of COVID-19 on sleep and alcohol use so that we will be better prepared to prevent and treat psychological effects of COVID-19 pandemic or similar outbreaks in the future.

“The significance of addressing health and other inequities has never been greater,” said Nancy Schoenberg, CHET director. “While we received numerous rigorous proposals, these projects stood out for their capacity to employ stellar research approaches to make impactful change."

The ambitious study is organized into six phases, beginning with the basic preparations and leading into actual implementation and monitoring of various evidence-based strategies to reduce opioid deaths.

A new study led by UK researcher April Young and Emory researcher Hannah Cooper shows that a number of pharmacies in the Appalachian region of Kentucky are limiting the dispensing of buprenorphine, a medication used to treat opioid use disorder (OUD).

"It's a wonderful showcase of the breadth and depth of our research." Substance Use Research Day highlights the impactful work of UK faculty, staff and students.